Tuesday, July 14, 2020

FDA Issues Draft Guidances to Help Facilitate the Development of New Animal Drug Submissions
Today the U.S. Food and Drug Administration (FDA) is announcing the availability of four draft guidance documents that, if finalized, will help encourage animal drug sponsors to use innovative approaches as they prepare data submissions related to new animal drug products for agency evaluation and review, as part of the FDA’s new animal drug approval process. The recommendations in these guidance documents align with those already issued by FDA’s other medical product centers.

1 comment:

i3cglobal said...

Nice reading, I love your content. This is really a fantastic and informative post. Keep it up and if you are looking for FDA 510k then visit I3CGLOBAL